Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
21 | Current Pharmacogenomics and Personalized Medicine | journal | 0.112 Q4 | 20 | 21 | 56 | 1270 | 6 | 50 | 0.16 | 60.48 | 33.96 | |
20 | Current Cancer Therapy Reviews | journal | 0.140 Q4 | 17 | 15 | 63 | 860 | 12 | 52 | 0.22 | 57.33 | 50.00 | |
19 | Turkish Journal of Pharmaceutical Sciences | journal | 0.152 Q4 | 22 | 54 | 119 | 1620 | 59 | 119 | 0.45 | 30.00 | 55.67 | |
18 | Current Enzyme Inhibition | journal | 0.153 Q4 | 19 | 20 | 61 | 698 | 26 | 54 | 0.34 | 34.90 | 50.00 | |
17 | Letters in Drug Design and Discovery | journal | 0.207 Q4 | 37 | 162 | 385 | 5795 | 335 | 381 | 0.93 | 35.77 | 42.26 | |
16 | Current Pharmaceutical Analysis | journal | 0.218 Q4 | 27 | 82 | 177 | 2329 | 119 | 168 | 0.70 | 28.40 | 47.71 | |
15 | Open Medicinal Chemistry Journal | journal | 0.237 Q4 | 23 | 12 | 22 | 455 | 24 | 22 | 1.26 | 37.92 | 42.86 | |
14 | Current Computer-Aided Drug Design | journal | 0.265 Q4 | 32 | 38 | 113 | 1534 | 109 | 95 | 1.03 | 40.37 | 31.20 | |
13 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.293 Q4 | 45 | 31 | 66 | 1834 | 76 | 61 | 1.00 | 59.16 | 20.24 | |
12 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.351 Q4 | 39 | 22 | 92 | 1459 | 96 | 77 | 0.97 | 66.32 | 41.10 | |
11 | Infectious Disorders - Drug Targets | journal | 0.351 Q4 | 61 | 34 | 83 | 1174 | 85 | 74 | 0.87 | 34.53 | 38.65 | |
10 | International Journal of Molecular and Cellular Medicine | journal | 0.415 Q4 | 22 | 28 | 66 | 1004 | 110 | 62 | 1.67 | 35.86 | 32.62 | |
9 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.528 Q3 | 108 | 218 | 518 | 13123 | 1043 | 487 | 1.91 | 60.20 | 41.37 | |
8 | Mini-Reviews in Medicinal Chemistry | journal | 0.609 | 107 | 124 | 419 | 9892 | 1022 | 373 | 2.49 | 79.77 | 37.37 | |
7 | Analytical Cellular Pathology | journal | 0.700 Q3 | 35 | 45 | 75 | 2369 | 181 | 75 | 2.21 | 52.64 | 48.70 | |
6 | Current Molecular Pharmacology | journal | 0.774 Q3 | 49 | 34 | 99 | 2857 | 178 | 83 | 1.22 | 84.03 | 45.99 | |
5 | Current Drug Targets | journal | 0.825 Q3 | 119 | 171 | 558 | 16711 | 1326 | 491 | 2.22 | 97.73 | 41.62 | |
4 | Current Medicinal Chemistry | journal | 0.918 Q2 | 202 | 332 | 835 | 40345 | 2886 | 780 | 3.22 | 121.52 | 45.73 | |
3 | Current Gene Therapy | journal | 1.008 Q2 | 80 | 41 | 139 | 3484 | 338 | 128 | 2.16 | 84.98 | 42.50 | |
2 | Nanomedicine Research Journal | journal | 20 | 32 | 48 | 1093 | 65 | 48 | 1.35 | 34.16 | 51.16 | ||
1 | Turkish Computational and Theoretical Chemistry | journal | 8 | 10 | 0 | 285 | 0 | 0 | 0.00 | 28.50 | 28.57 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®